4.0
22 Mar 2026
Current employee, more than 1 year
Amsterdam
Recommend
CEO approval
Business outlook
Pros
Exposure to multiple clinical trial projects with varying complexity and stakeholders
Cons
Deadlines frequently imposed without proper alignment, leading to unnecessary pressure